Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma

Glioblastoma is an aggressive brain tumour with a patient median survival of approximately 14 months. The development of innovative treatment strategies to increase the life span and quality of life of patients is hence essential. This requires the use of appropriate glioblastoma models for preclini...

Descripción completa

Detalles Bibliográficos
Autores principales: Meneceur, Sarah, Linge, Annett, Meinhardt, Matthias, Hering, Sandra, Löck, Steffen, Bütof, Rebecca, Krex, Dietmar, Schackert, Gabriele, Temme, Achim, Baumann, Michael, Krause, Mechthild, von Neubeck, Cläre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226316/
https://www.ncbi.nlm.nih.gov/pubmed/32260145
http://dx.doi.org/10.3390/cancers12040871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226316/
https://www.ncbi.nlm.nih.gov/pubmed/32260145
http://dx.doi.org/10.3390/cancers12040871

Ejemplares similares